Xyall and Indica Labs forge global collaboration
The partnership is designed to bridge the gap between histopathology and molecular pathology
18 Apr 2023
Xyall and Indica Labs have entered into a global strategic partnership to unite Xyall’s automated tissue dissection solutions with Indica Labs’ AI-powered, diagnostic digital pathology platform.
Selecting tumor tissue is at the heart of molecular diagnostic testing. The collaboration will enable molecular laboratories to benefit from a fully digital and automated workflow for tissue macro dissection for molecular diagnostic testing, providing increased throughput and accuracy at lower operational cost.
While the field of molecular diagnostics has seen great advances in next-generation sequencing technology, alongside the rapid adoption of digital pathology, tissue dissection has remained a manual, labor-intensive process, with limited precision and a high sensitivity to errors.
The partnership enables Xyall automated Tissector tissue dissection solutions to capitalize on the HALO AP® anatomic pathology image management and workflow software from Indica Labs, which facilitates primary diagnosis, remote slide review, case sign-out and more.
Xyall offers two solutions that enable molecular pathology laboratories to fully automate their tumor tissue dissection workflow. Its Tissector High Throughput (HT) system has been designed to meet the needs of high-volume molecular laboratories. The combined Tissector HT and HALO AP systems are already in use in a large commercial lab setting.The latest Xyall platform, the compact Tissector Table Top (TT) solution, is designed to meet the needs of lower-volume molecular laboratories.
The HALO AP is a CE-IVD-certified software platform that brings remote slide review, case-centric digital pathology slide management, collaboration and AI-powered quantitative image analysis to anatomic pathology labs worldwide. HALO AP features a streamlined user interface that makes analysis and annotation of slides simple and easy. Slide annotations from HALO AP are automatically simplified and transferred to the Tissector system for tumor tissue dissection. Future deployments including tumor-detecting AI and cell-quantification algorithms via the HALO AP workflow-based interface promise pathologists even more tools for tumor content assessment.
